Evaluation of cataract surgery and lens implantation in diabetics

ISRCTN ISRCTN93583656
DOI https://doi.org/10.1186/ISRCTN93583656
Secondary identifying numbers 09/H0402/107
Submission date
30/10/2009
Registration date
15/12/2009
Last edited
02/10/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Not provided at time of registration

Contact information

Mr David Spalton
Scientific

Ophthalmology Department
St Thomas' Hospital
Westminster Bridge Road
London
SE1 7EH
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleComparison of glistenings in two hydrophobic acrylic intraocular lenses after cataract surgery in diabetics: a randomised controlled trial
Study hypothesisHydrophobic acrylic intraocular lenses (IOL) account for the majority of the market in the UK. In some patients microvacuoles known as glistenings are seen to form in the IOL material in the first 2 years after surgery. These do not affect visual acuity after surgery, but could cause light scatter in the eye and glare. They are seen more commonly clinically in eyes with damaged blood aqueous barriers, such as in diabetes or uveitis.

Recently a new intraocular lens (AVS) which has a slightly higher water content (4% versus less than 1%) does not appear to develop glistenings. The aim of this study is to compare this IOL with a standard hydrophobic IOL in diabetic patients.
Ethics approval(s)St Thomas' Research Ethics Committee, 27/10/2009
ConditionCataract
InterventionAVS hydrophobic intraocular lens versus AcrySof® intraocular lens. Patients will be randomised to have routine cataract surgery to one eye with implantation of either the Santen or the AcrySof® lens. Randomisation will be via a remote computer based website. Surgery to the second eye will be performed within 6 weeks of the first operation by the same surgeon, with the other intraocular lens type.

Patients will be followed up for a total of 3 years.
Intervention typeProcedure/Surgery
Primary outcome measure1. Glistenings
2. Vision
Taken at 1, 3, 6, 12, 24 and 36 months.
Secondary outcome measures1. Post-operative inflammation after cataract surgery and cellular deposition on the IOL surface
2. Objective optical quality and wave-front aberration
3. Contrast sensitivity
4. Diabetic retinopathy after cataract surgery
Taken at 1, 3, 6, 12, 24 and 36 months.
Overall study start date01/01/2010
Overall study end date01/01/2013

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants40
Participant inclusion criteria1. Bilateral cataracts requiring surgery
2. Diabetic
3. Aged 18 years or over, either sex
Participant exclusion criteriaDiabetic maculopathy
Recruitment start date01/01/2010
Recruitment end date01/01/2013

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

St Thomas' Hospital
London
SE1 7EH
United Kingdom

Sponsor information

Guys and St Thomas' Hospital NHS Foundation Trust (UK)
Hospital/treatment centre

c/o Karen Ignatian
London
SE1 7EH
England
United Kingdom

Website http://www.guysandstthomas.nhs.uk/
ROR logo "ROR" https://ror.org/00j161312

Funders

Funder type

Charity

Fight for Sight (UK)
Government organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
Fight for Sight, Inc., National Council to Combat Blindness, Fight for Sight (U.S.), FFS
Location
United States of America
Advanced Vision Science (AVS) (UK) - providing intraocular lenses

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

02/10/2017: No publications found, verifying study status with principal investigator.